why choose us

First received: November 30, 2022

Clinical Trial: Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Univentricular Heart

Study Type: INTERVENTIONAL


Official Title: Safety and Feasibility of Autologous Induced Pluripotent Stem Cells of Cardiac Lineage in Subjects With Congenital Heart Disease

Brief Summary: The goal of this clinical trial is to test the safety of lab-grown heart cells made from stem cells in subjects with congenital heart disease.The main questions it aims to answer are:Is this product safe to deliver to humansIs the conduct of this trial feasibleParticipants will be asked to:Agree to testing and monitoring before and after product administrationReceive investigational productAgree to lifelong follow-up Researchers will compare subjects from the same pool to see if there is a difference between…

Read more